O Fluge
Overview
Explore the profile of O Fluge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
6723
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pauly F, Fjorden K, Leppa S, Holte H, Bjorkholm M, Fluge O, et al.
Blood Cancer J
. 2016 Nov;
6(11):e501.
PMID: 27858932
No abstract available.
2.
Kiserud C, Fagerli U, Smeland K, Fluge O, Bersvendsen H, Kvaloy S, et al.
Acta Oncol
. 2016 Apr;
55(5):547-53.
PMID: 27123741
Background This study examined employment patterns and associated factors in lymphoma survivors treated with high-dose chemotherapy with autologous stem cell transplantation (HDT-ASCT) from diagnosis to a follow-up survey at a...
3.
Holte H, Leppa S, Bjorkholm M, Fluge O, Jyrkkio S, Delabie J, et al.
Ann Oncol
. 2012 Dec;
24(5):1385-92.
PMID: 23247661
Background: Many patients with aggressive B-cell lymphomas and high clinical risk score still die of lymphoma after conventional R-CHOP chemoimmunotherapy. We hypothesized that intensified chemoimmunotherapy including systemic central nervous system...
4.
Knudsen-Baas K, Moen G, Fluge O, Storstein A
Acta Neurol Scand Suppl
. 2012 Nov;
(196):31-7.
PMID: 23190289
Pseudoprogression is a treatment-related effect seen on imaging in high-grade glioma. Enhancement of gadolinium contrast on control MRI can be misinterpreted as tumor recurrence and is also difficult to distinguish...
5.
Myklebust M, Li Z, Tran T, Rui H, Knudsen E, Elsaleh H, et al.
Br J Cancer
. 2012 Oct;
107(10):1684-91.
PMID: 23099809
Background: The aim of this study was to investigate the value of the cyclin D1 isoforms D1a and D1b as prognostic factors and their relevance as predictors of response to...
6.
Myklebust M, Fluge O, Immervoll H, Skarstein A, Balteskard L, Bruland O, et al.
Br J Cancer
. 2012 Feb;
106(4):756-62.
PMID: 22333708
Background: Our purpose was to investigate if dysregulation of cell adhesion molecules could be linked to prognosis in squamous cell carcinomas (SCCs) of the anal region. Methods: Protein expression of...
7.
Myklebust M, Bruland O, Fluge O, Skarstein A, Balteskard L, Dahl O
Br J Cancer
. 2011 Nov;
105(11):1719-25.
PMID: 22045185
Background: MicroRNAs (miRNAs) are important regulators of cellular processes and are found to be deregulated in many cancers. We here analysed the miRNA expression in anal carcinomas. In a previous...
8.
Fluge O, Gravdal K, Carlsen E, Vonen B, Kjellevold K, Refsum S, et al.
Br J Cancer
. 2009 Sep;
101(8):1282-9.
PMID: 19773751
Background: Enhancer of zeste homologue 2 (EZH2) is a member of the Polycomb group of genes that is involved in epigenetic silencing and cell cycle regulation. Methods: We studied EZH2...
9.
Bruland O, Fluge O, Immervoll H, Balteskard L, Myklebust M, Skarstein A, et al.
Br J Cancer
. 2008 Mar;
98(7):1264-73.
PMID: 18349847
Human papillomavirus (HPV) is a major aetiological agent in anal carcinomas. We here present a study of global gene expression using microarray hybridisation in a collection of anal carcinoma biopsies....
10.
Omenaas E, Fluge O, Buist A, Vollmer W, Gulsvik A
Respir Med
. 2003 Feb;
97(2):134-42.
PMID: 12587963
We aimed to investigate whether dietary vitamin C intake, an important antioxidant, is inversely related to self-reported respiratory symptoms in young adults of a community. A random sample of 4300...